Alembic Pharma (ALPM) exhibited in-line revenue with a slight miss on EBITDA/PAT for the quarter. While ex-US export growth was strong for the quarter, it was offset by moderate YoY growth in domestic ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...

Alembic Pharmaceuticals Limited (Alembic) announced that it has received final approval from the US Food & Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) difluprednate ...

Fintel reports that on January 15, 2026, Alembic Global initiated coverage of ATI (NYSE:ATI) with a Overweight recommendation. Analyst Price Forecast Suggests 1.04% Downside As of January 14, 2026, ...

Alembic Pharmaceuticals Limited (Alembic), a vertically integrated research and development pharmaceutical company, announced that it has received tentative approval from the US Food & Drug ...

Alembic Pharmaceuticals was hit with a patent infringement lawsuit on Dec. 19 in New York Eastern District Court over its planned generic version of the glaucoma treatment LUMIGAN®. The action, ...

Mohsen Baqery is a Staff Writer at GameRant based in Turkey. He mainly covers video game news and industry features while occasionally publishing guides and listicles. Mohsen started his journey into ...

Causal artificial intelligence startup Alembic Technologies Inc. said today it has raised $145 million in a Series B growth round that increases its valuation almost 16-fold. It’s using a big chunk of ...

Alembic Technologies has raised $145 million in Series B and growth funding at a valuation 15 times higher than its previous round, betting that the next competitive advantage in artificial ...

Community driven content discussing all aspects of software development from DevOps to design patterns. Ready to develop your first AWS Lambda function in Python? It really couldn’t be easier. The AWS ...